Home›Stock Screener›Aspira Pathlab

Aspira Pathlab Share Price Today | Stock Price & Aspira Pathlab Share Screener

ASPIRA Healthcare Services
Live Share Price BSE
₹131.00
▼ -4.65 (-3.43%)
2026-11-20 00:00:00

As of November 20, 2026, the live Aspira Pathlab share price (BSE: ASPIRA) is ₹131.00, down 3.43% from the previous close, with shares trading between ₹131.00 and ₹138.95 in today's trading session, and a 52-week range of ₹54.00–₹143.34. Track ASPIRA company valuation to gauge the company's total market size. Use the Aspira Pathlab stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Aspira Pathlab opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Aspira Pathlab Market Cap ₹141.54 Cr.
ASPIRA P/E Ratio (TTM) -39.10
Aspira Pathlab P/B Ratio 12.22
EPS (TTM) ₹1.97
Dividend Yield -
Debt to Equity 0.15
ASPIRA 52 Week High ₹143.34
Aspira Pathlab 52 Week Low ₹54.00
Operating Margin 13.00%
Profit Margin -
ASPIRA Revenue (TTM) ₹5.00
EBITDA ₹1.00
Net Income -
Total Assets ₹18.00
Total Equity ₹12.00

Aspira Pathlab Share Price Chart

Track the current stock price of Aspira Pathlab with an interactive chart. Analyse ASPIRA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Aspira Pathlab stock quote in one place.

The quote of ₹131.00 sits between the 52-week low of ₹54.00 and the 52-week high of ₹143.34, and the latest session moved -3.43% from the previous close.

Aspira Pathlab Company Profile - Fundamental Screener

Screen Aspira Pathlab company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ASPIRA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Services industry, and it trades under ISIN INE500C01017.

Company Details

Classification

Sector Healthcare
Industry Healthcare Services
Sub-Sector Healthcare Services
Segment E

Identifiers and Leadership

ISIN INE500C01017

Aspira Pathlab Balance Sheet Screener

Screen ASPIRA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2025, total assets were ₹18, up from ₹15 in 2024.

Latest statistics put total assets at ₹18 and shareholder funds at ₹12, with a leverage ratio of 0.15.

Item 2025 2024

Assets

Total Assets 18 15
Current Assets 0 0
Fixed Assets 7 7

Liabilities

Total Liabilities 0 0
Current Liabilities 3 3
Non-Current Liabilities 0 0

Shareholders' Equity

Total Equity 12 10
Share Capital 10 10
Reserves & Surplus -3 -5

Aspira Pathlab Income Statement Screener - Profit & Revenue Analysis

Screen Aspira Pathlab income statement and profit fundamentals. Analyze ASPIRA quarterly results. Aspira Pathlab reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2025-Jun, revenue was ₹5 and net profit was ₹0, equal to earnings per unit of ₹0.41, at an operating margin of 13%.

In that period expenses were ₹5, interest cost ₹0 and tax ₹0. The next period listed, 2025-Mar, shows revenue of ₹6 and net profit of ₹1.

Item 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Jun

Revenue and Expenses

Revenue 5 6 6 6 5 4 3
Expenses 5 5 5 5 4 4 3

Operating Costs and Margins

EBITDA 1 1 1 1 0 0 0
Operating Profit % 13.00% 16.00% 11.00% 21.00% 6.00% -5.00% -17.00%
Depreciation 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 0 1 0 1 0 -1 -1
Tax 0 0 0 0 0 0 0
Net Profit 0 1 0 1 0 -1 -1
EPS 0.41 0.66 0.30 0.96 0.05 -0.49 -0.70

Aspira Pathlab Cash Flow Screener - Liquidity Fundamentals

Screen ASPIRA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities generated ₹2, and net cash flow was an inflow of ₹1.

Over the same period, investing activities provided ₹0 and financing activities used ₹1.

Item 2025-March 2024-March

Cash from Operations and Investing

Operating Activities 2 1
Investing Activities 0 0

Financing and Net Cash

Financing Activities -1 -1
Net Cash Flow 1 0

Aspira Pathlab Shareholding Pattern Screener

See Aspira Pathlab shareholding pattern with promoter, FII, and DII holdings. Check Aspira Pathlab promoter holding and ownership changes for ASPIRA on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 18.39%, foreign institutions 0.00%, domestic institutions 0.00% and the public 60.06%, spread across 1,769 shareholders.

The shareholder count was 1,769 in 2026-Mar, compared with 1,620 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 18.39% 46.58% 46.65% 18.39% 18.39% 18.39% 18.39% 18.72%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 60.06% 40.70% 47.12% 60.46% 60.28% 60.16% 60.07% 55.71%
Other Holding 21.55% 12.72% 6.24% 21.15% 21.33% 21.45% 21.54% 25.57%
Shareholder Count 1,769 1,620 1,603 1,741 1,770 1,755 1,784 1,512

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Aspira Pathlab. Aspira Pathlab dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Aspira Pathlab.

Aspira Pathlab Stock Index Membership - Nifty & Sensex

See which indices include Aspira Pathlab stock. Check ASPIRA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Aspira Pathlab is not part of any tracked indices.
Only major market indices are tracked in our system.

Aspira Pathlab Market Events Screener - Corporate Actions

Get Aspira Pathlab corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Aspira Pathlab stock events that may affect ASPIRA share price, along with derivatives, futures and options activity and sector gainers.

12 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 6, 2026, with a record date of November 6, 2026.

It is followed by Annual General Meeting dated September 25, 2026 and Quarterly Result Announcement dated August 12, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-06 2026-11-06 Quarterly Result Announcement NA 3.74%
2026-09-25 2026-09-25 Annual General Meeting NA 42.04%
2026-08-12 2026-08-12 Quarterly Result Announcement NA -7.64%
2026-05-23 2026-05-23 Quarterly Result Announcement NA 24.57%
2026-02-10 2026-02-10 Quarterly Result Announcement NA 13.68%
2025-11-12 2025-11-12 Quarterly Result Announcement NA -0.33%
2025-09-26 2025-09-26 Annual General Meeting NA -1.79%
2025-08-12 2025-08-12 Quarterly Result Announcement NA -6.20%
2025-05-16 2025-05-16 Quarterly Result Announcement NA -12.33%
2025-02-07 2025-02-07 Quarterly Result Announcement NA -9.00%
2024-11-12 2024-11-12 Quarterly Result Announcement NA 23.16%
2024-09-27 2024-09-27 Annual General Meeting NA 27.67%

Aspira Pathlab Competitors Screener - Peer Stocks Comparison

Screen ASPIRA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Apollo Hospitals 124,970 53.90 25,420 15.58% 2,003 64.36
Max Healthcare Institute 100,339 71.20 8,536 18.82% 1,442 73.63
Manipal Health Enterprises 92,333 104.20 10,521 25.80% 917 58.01
Aster DM Quality Care 64,482 116.10 4,769 11.25% 427 61.53
Fortis Healthcare 61,152 57.00 9,179 16.93% 1,064 56.49
Narayana Hrudayalaya 39,012 45.00 7,996 43.43% 811 60.17
Global Health 38,806 62.80 4,509 19.56% 554 63.26
Dr. Lal Path Labs 33,375 57.20 2,864 12.11% 510 57.81
Krishna Institute of Medical Sciences 32,212 163.00 3,931 28.16% 242 65.46
Syngene International 17,543 95.70 3,809 2.56% 317 66.04

Aspira Pathlab Company Announcements - News & Reports Screener

Screen ASPIRA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 19, 2026.

The next most recent announcements are dated November 19, 2026 and November 12, 2026.

Date Update Actions
2026-11-19 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-11-19 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-11-12 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-12 Financial Result For Half Year Ended 30Th September 2026 -
2026-11-12 Board Meeting Outcome for Outcome Of Board Meeting Dated 6Th November 2026 -
2026-10-31 Board Meeting Intimation for Board Meeting To Be Held On November 06 2026 For The Second Quarter/Half Year Ended September 30 2026 -
2026-10-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-01 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-09-28 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-09-25 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-25 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-23 Closure of Trading Window -
2026-09-16 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-09-12 Announcement Under Regulation 30_Constitution Of Right Issue Committee -
2026-09-12 Announcement under Regulation 30 (LODR)-Raising of Funds -
2026-09-12 Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th September 2026 -
2026-09-12 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-09-07 Board Meeting Intimation for To Consider Approve The Proposal For Raising Funds Through The Issuance Of Equity Shares Warrants Convertible Into Equity Shares Or Other Permitted Instruments By Way Of Preferential Issue Private Placement Rights Issue Or Any -
2026-09-05 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-09-03 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹131.00, within a 52-week range of ₹54.00 to ₹143.34. The P/E ratio is -39.10 and the P/B ratio is 12.22, with earnings per unit of ₹1.97. Market capitalisation stands at ₹141.54 Cr. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on November 22, 2026. This page covers 2 balance sheet periods, 7 income statement periods, 2 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.